The device is called TRU-D SmartUVC, which will help in disinfecting health care environments where Ebola patients are being treated.
TRU-D features Sensor360 technology, which calculates the time needed to react to room variables such as size, geometry, surface reflectivity and the amount and location of equipment in the room.
The device is said to effectively deliver a lethal dose of UV-C light during a single cycle from a single and central location in the room and works by generating UV light energy that modifies the DNA structure of viral pathogens such as Ebola.
TRU-D’s inventor and a Fellow in the Royal Society of Tropical Medicine and Hygiene Dr Jeffery Deal said that TRU-D SmartUVC technology has been developed to combat the devastating effects of hospital acquired infections.
"Unlike many diseases, Ebola strikes hospital workers more than any other group, making it the ultimate hospital acquired infection," Deal added.
The health care providers in the US, Canada, the UK and Saudi Arabia are using TRU-D to eliminate pathogens such as Ebola, Middle East Respiratory Syndrome (MERS), influenza, norovirus, Clostridium difficile, Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE).
The Ebola virus causes viral hemorrhagic fever disease, which is highly contagious through bodily fluid transmission.
The disease symptoms include fever, headache, weakness, achiness, diarrhea, vomiting, stomach pain, lack of appetite and abdominal bleeding.
